Market Cap 164.57M
Revenue (ttm) 13.56M
Net Income (ttm) -35.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -262.32%
Debt to Equity Ratio 0.00
Volume 354,100
Avg Vol 619,016
Day's Range N/A - N/A
Shares Out 97.96M
Stochastic %K 63%
Beta 1.42
Analysts Strong Sell
Price Target $2.03

Company Profile

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departm...

Industry: Medical Devices
Sector: Healthcare
Phone: 866 796 6767
Address:
351 New Whitfield Street, Guilford, United States
MorganHoratio
MorganHoratio May. 8 at 1:36 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: $HYPR - 898,720 $LYEL - 293,256 $MAZE - 1,388,583 $GLUE - 684,275 $OSCR - 481,988 Google's Q1 13F reveals a sharp focus: Cybersecurity Bedrock + AI Bio-Engineering! The stake in $HYPR is a massive signal—in a 2026 defined by AI deepfakes, Google is leaning on $HYPR's passwordless tech to fortify its Gemini ecosystem. Meanwhile, the heavy lifting in $MAZE and $GLUE proves Alphabet is no longer just indexing information, but indexing "cures" through AI-led protein modeling. With $OSCR hitting its profitability inflection point, do you think Google is just building an AI-health moat, or are we looking at the early days of its next multi-billion dollar "Other Bet" breakout? Let's discuss your top small-cap pick!
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 8 at 11:27 AM
$HYPR The panel discussion was very positive. They made it sound like a no-brainer for a hospital to buy one. In fact, one Doctor said he was probably buying two more. One of these days, Swoop sales are going to explode! But waiting for it is like watching paint dry ...
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 8 at 11:24 AM
0 · Reply
permedbull
permedbull May. 8 at 4:48 AM
$HYPR 🚩
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 6 at 10:30 PM
$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-participate-upcoming-2026-jefferies-global
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 6 at 8:23 PM
$HYPR Tomorrow at 4:00, there is a panel discussion: “How portable MRI is transforming stroke care and unlocking scalable stroke programs” I got an email invite
0 · Reply
white_knuckling
white_knuckling May. 5 at 1:41 PM
$HYPR y the drop this morning?
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 5 at 12:20 PM
$HYPR All we need is one big order from a large hospital chain and we are headed to $3.00 !!!
0 · Reply
permedbull
permedbull May. 4 at 7:00 PM
$HYPR some of this new volume must be going to toots
0 · Reply
permedbull
permedbull May. 4 at 6:05 PM
$HYPR its that time
0 · Reply
Latest News on HYPR
Hyperfine initiated with a Buy at BTIG

2026-04-29T11:33:03.000Z - 10 days ago

Hyperfine initiated with a Buy at BTIG


Horizon Technology provides $40M loan facility to Hyperfine

2026-03-23T12:10:42.000Z - 6 weeks ago

Horizon Technology provides $40M loan facility to Hyperfine

HRZN


Hyperfine price target raised to $1.60 from $1.30 at B. Riley

2026-03-19T12:56:16.000Z - 7 weeks ago

Hyperfine price target raised to $1.60 from $1.30 at B. Riley


Hyperfine price target raised to $2.50 from $2 at Lake Street

2026-03-19T12:45:51.000Z - 7 weeks ago

Hyperfine price target raised to $2.50 from $2 at Lake Street


Hyperfine Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 7 weeks ago

Hyperfine Earnings Call Transcript: Q4 2025


Hyperfine reports Q4 EPS (6c) vs (14c) last year

2026-03-18T20:12:26.000Z - 7 weeks ago

Hyperfine reports Q4 EPS (6c) vs (14c) last year


Hyperfine sees FY26 revenue $20M-$22M, one estimate $18M

2026-03-18T20:12:21.000Z - 7 weeks ago

Hyperfine sees FY26 revenue $20M-$22M, one estimate $18M


Hyperfine announces results from NEURO PMR study

2026-01-20T13:20:42.000Z - 3 months ago

Hyperfine announces results from NEURO PMR study


Hyperfine enrolls first patient in Contrast PMR study

2026-01-15T13:21:26.000Z - 4 months ago

Hyperfine enrolls first patient in Contrast PMR study


Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M

2026-01-12T13:41:42.000Z - 4 months ago

Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M


Hyperfine receives $3.7M Gates Foundation grant

2025-11-19T13:45:26.000Z - 6 months ago

Hyperfine receives $3.7M Gates Foundation grant


Hyperfine Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

Hyperfine Earnings Call Transcript: Q3 2025


Hyperfine reports Q3 EPS (14c) vs. (14c) last year

2025-11-13T21:10:51.000Z - 6 months ago

Hyperfine reports Q3 EPS (14c) vs. (14c) last year


Hyperfine sees Q4 revenue $5M-$6M, consensus $6.0M

2025-11-13T21:10:34.000Z - 6 months ago

Hyperfine sees Q4 revenue $5M-$6M, consensus $6.0M


Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:05 PM EST - 6 months ago

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results


Hyperfine enrolls first patient in PRISM PMR study

2025-10-21T13:10:40.000Z - 7 months ago

Hyperfine enrolls first patient in PRISM PMR study


Hyperfine 14M share Spot Secondary priced at $1.25

2025-10-16T12:40:46.000Z - 7 months ago

Hyperfine 14M share Spot Secondary priced at $1.25


Hyperfine Announces Pricing of $17.5 Million Public Offering

Oct 16, 2025, 8:00 AM EDT - 7 months ago

Hyperfine Announces Pricing of $17.5 Million Public Offering


Hyperfine sees Q3 revenue $3.4M, consensus $3.51M

2025-10-15T20:10:43.000Z - 7 months ago

Hyperfine sees Q3 revenue $3.4M, consensus $3.51M


Hyperfine Announces Proposed Public Offering

Oct 15, 2025, 4:06 PM EDT - 7 months ago

Hyperfine Announces Proposed Public Offering


Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Aug 25, 2025, 8:15 AM EDT - 9 months ago

Hyperfine, Inc. to Participate in Upcoming Investor Conferences


Hyperfine Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 9 months ago

Hyperfine Earnings Call Transcript: Q2 2025


Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:05 PM EDT - 9 months ago

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results


Hyperfine Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q1 2025


Hyperfine, Inc. Reports First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports First Quarter 2025 Financial Results


Hyperfine Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q4 2024


Hyperfine Announces $6.0 Million Registered Direct Offering

Feb 11, 2025, 8:02 AM EST - 1 year ago

Hyperfine Announces $6.0 Million Registered Direct Offering


MorganHoratio
MorganHoratio May. 8 at 1:36 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: $HYPR - 898,720 $LYEL - 293,256 $MAZE - 1,388,583 $GLUE - 684,275 $OSCR - 481,988 Google's Q1 13F reveals a sharp focus: Cybersecurity Bedrock + AI Bio-Engineering! The stake in $HYPR is a massive signal—in a 2026 defined by AI deepfakes, Google is leaning on $HYPR's passwordless tech to fortify its Gemini ecosystem. Meanwhile, the heavy lifting in $MAZE and $GLUE proves Alphabet is no longer just indexing information, but indexing "cures" through AI-led protein modeling. With $OSCR hitting its profitability inflection point, do you think Google is just building an AI-health moat, or are we looking at the early days of its next multi-billion dollar "Other Bet" breakout? Let's discuss your top small-cap pick!
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 8 at 11:27 AM
$HYPR The panel discussion was very positive. They made it sound like a no-brainer for a hospital to buy one. In fact, one Doctor said he was probably buying two more. One of these days, Swoop sales are going to explode! But waiting for it is like watching paint dry ...
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 8 at 11:24 AM
0 · Reply
permedbull
permedbull May. 8 at 4:48 AM
$HYPR 🚩
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 6 at 10:30 PM
$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-participate-upcoming-2026-jefferies-global
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 6 at 8:23 PM
$HYPR Tomorrow at 4:00, there is a panel discussion: “How portable MRI is transforming stroke care and unlocking scalable stroke programs” I got an email invite
0 · Reply
white_knuckling
white_knuckling May. 5 at 1:41 PM
$HYPR y the drop this morning?
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 5 at 12:20 PM
$HYPR All we need is one big order from a large hospital chain and we are headed to $3.00 !!!
0 · Reply
permedbull
permedbull May. 4 at 7:00 PM
$HYPR some of this new volume must be going to toots
0 · Reply
permedbull
permedbull May. 4 at 6:05 PM
$HYPR its that time
0 · Reply
djp70
djp70 May. 4 at 2:58 PM
$HYPR $ This one is just getting started.
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 4 at 2:04 PM
$BFLY $HYPR Both BFLY and HYPR invented by Dr. Rothberg. BFLY is the next gen, AI powered Ultrasound, HYPR is the next gen, AI powered MRI. BFLY is growing revenues at 21%, HYPR is growing at 48%. BFLY has a $1,368M market cap HYPR has a $184M market cap. I believe that HYPR has much more upside than BFLY. Buying HYPR here is like buying BFLY at $1.87…
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 3 at 1:12 PM
$HYPR I think there should be a Swoop "Concussion scanner" on every NFL field. Also, they should be required on all College and High School football fields to scan for concussion and protect our kids/athletes.
0 · Reply
alpharesearch
alpharesearch May. 2 at 10:55 PM
$HYPR - Positive Catalysts: Upcoming Q1 earnings (May 12) could drive further gains amid revenue momentum (Q4 beat expectations). International expansion (India, Europe), AI/software upgrades, and analyst support signal path to profitability. Strong Buy consensus implies...
0 · Reply
alpharesearch
alpharesearch May. 2 at 4:48 PM
Top performers - 05-01-2026 - Small Cap. Commercial Services : $ATOM.X Communications : $OOMA Consumer Durables : $JAKK Consumer Non-Durables : $WEST Consumer Services : $IHRT Distribution Services : $TITN Electronic Technology : $MRAM Energy Minerals : $OBE Finance : $GAIN Health Services : $AGL Health Technology : $HYPR Industrial Services : $MG Miscellaneous : $NRK Non-Energy Minerals : $NWPX Process Industries : $AMTX Producer Manufacturing : $NNBR Retail Trade : $HNST Technology Services : $BAND Transportation : $UP Utilities : $CLNE
0 · Reply
StockScanners
StockScanners May. 2 at 3:33 PM
$HYPR keep watch if this holds above 1.82
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 1 at 11:14 PM
$HYPR this is an idea that I haven’t seen anyone else talk about, but it makes a lot of sense. https://x.com/jeffgabel/status/1963413561046139162?s=61
1 · Reply
STACKD0E
STACKD0E May. 1 at 8:27 PM
$HYPR 🫠
0 · Reply
Stockwhisperr
Stockwhisperr May. 1 at 7:37 PM
$BFLY Day traders and penny flippers will be gone in the coming weeks. Long term investors in pursuit of life changing generational wealth will wait as BFLY grows. I predicted years ago that of the three companies Jonathan Rothberg founded $QSI $HYPR $BFLY would be the biggest winner to change the world and create life changing ROI. The pipeline with these and many other opportunities will begin to push the stock to new highs and levels we haven’t seen since BFLY went public via a Spac. - Butterfly Home and Community Care - Butterfly Embedded - Butterfly Garden - Compass AI - Apollo - X - iQ Workstations - iQ4 and iQ5 - EU Lead Based Exemption Decision The chip, software and IP that Butterfly has is superior to any competitor despite what you might hear from the mainstream and social media. Within three years of Joe DeVivo taking over as CEO revenues have doubled. They will quickly grow to $500-600 million by 2032 and the stock will be triple digits. Few Understand 🦋
2 · Reply
white_knuckling
white_knuckling May. 1 at 3:34 PM
$HYPR not selling til 5$
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 1 at 3:33 PM
$HYPR The POWAH of the Russell 2000!!!
0 · Reply
annee33
annee33 May. 1 at 1:51 PM
$HYPR gap at $2
0 · Reply